$31.37
0.29[0.93%]
Last update: 12:47PM Get Real Time Here
Twist Bioscience
(NASDAQ:TWST)Latest News for Twist Bioscience Stock (NASDAQ:TWST)
Twist Bioscience Stock (NASDAQ: TWST)
Categories: All
Wednesday, April 10, 2024
Thursday, March 28, 2024
Monday, February 26, 2024
Friday, February 09, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Monday, February 05, 2024
- 4 Analysts Have This To Say About Twist BioscienceBenzinga Insights - Feb 5, 2024, 2:00PM
- Scotiabank Maintains Sector Outperform on Twist Bioscience, Raises Price Target to $43Benzinga Newsdesk - Feb 5, 2024, 1:18PM
- Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution At AGBTBenzinga Newsdesk - Feb 5, 2024, 8:24AM
Friday, February 02, 2024
- Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today?Vandana Singh - Feb 2, 2024, 12:58PM
- Twist Bioscience shares are trading higher after the company increased its FY24 revenue guidance.Benzinga Newsdesk - Feb 2, 2024, 11:51AM
- Twist Bioscience Expects Q2 FY24 Sales Of $70M-$71M Versus Consensus Of $70.01M, With Gross Margin Of 39%Benzinga Newsdesk - Feb 2, 2024, 7:42AM
- Twist Bioscience Increased FY24 Increased FY 2024 Gross Margin Guidance To 40%-41% Compared To 39%-40% Expected EarlierBenzinga Newsdesk - Feb 2, 2024, 7:34AM
- Twist Bioscience Increased FY24 Revenue Guidance To $288M To $293M Versus Prior Guidance Of $285M-$290M Versus Consensus Of $289.69MBenzinga Newsdesk - Feb 2, 2024, 7:34AM
- Twist Bioscience Q1 EPS $(0.75) Beats $(0.78) Estimate, Sales $71.50M Beat $67.58M EstimateBenzinga Newsdesk - Feb 2, 2024, 7:31AM
- Earnings Scheduled For February 2, 2024Benzinga Insights - Feb 2, 2024, 5:28AM
Thursday, February 01, 2024
Thursday, January 25, 2024
Wednesday, January 24, 2024
Thursday, January 18, 2024
Wednesday, January 17, 2024
- Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin ExpansionVandana Singh - Jan 17, 2024, 3:21PM
- Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Jan 17, 2024, 8:19AM
- Goldman Sachs Upgrades Twist Bioscience to Buy, Raises Price Target to $45Benzinga Newsdesk - Jan 17, 2024, 5:25AM
Friday, January 05, 2024
Tuesday, November 21, 2023
Friday, November 17, 2023
- S&P 500 Edges Higher; Buckle Shares Surge After Q3 EarningsLisa Levin - Nov 17, 2023, 2:30PM
- Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Nov 17, 2023, 1:01PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Nov 17, 2023, 12:31PM
- Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak SalesLisa Levin - Nov 17, 2023, 12:10PM
- Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On FridayLisa Levin - Nov 17, 2023, 11:02AM
- Twist Bioscience shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 2024 revenue guidance above estimates.Benzinga Newsdesk - Nov 17, 2023, 10:17AM
- Why Synthetic DNA Company Twist Bioscience Shares Are Jumping TodayVandana Singh - Nov 17, 2023, 10:04AM
- Twist Bioscience Expects Q1 FY24 Revenue Of $67M-$68M Vs. Consensus Of $62.98M, With Gross Margin Of Around 38%-39%Benzinga Newsdesk - Nov 17, 2023, 7:38AM
- Twist Bioscience Expects FY24 Revenue Of $285M-$290M Vs. Consensus Of $298.79M; Gross Margin Of Approximately 39%-40%Benzinga Newsdesk - Nov 17, 2023, 7:36AM
- Twist Bioscience: Q4 Earnings InsightsBenzinga Insights - Nov 17, 2023, 7:35AM
- Twist Bioscience Q4 EPS $(0.81) Beats $(0.92) Estimate, Sales $66.95M Beat $63.45M EstimateBenzinga Newsdesk - Nov 17, 2023, 7:33AM
- Earnings Scheduled For November 17, 2023Benzinga Insights - Nov 17, 2023, 5:33AM
Tuesday, November 14, 2023
Thursday, October 05, 2023
Wednesday, September 27, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023Benzinga Insights - Sep 27, 2023, 11:00AM
- Twist Bioscience And IMIDomics Collaborate To Discover Antibodies For Applications In Immune-Mediated Inflammatory DiseasesBenzinga Newsdesk - Sep 27, 2023, 8:03AM
- Berenberg Initiates Coverage On Twist Bioscience with Buy Rating, Announces Price Target of $27Benzinga Newsdesk - Sep 27, 2023, 6:20AM
Thursday, September 21, 2023
Thursday, August 31, 2023
Monday, August 07, 2023
Friday, August 04, 2023
- Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Aug 4, 2023, 12:55PM
- Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On FridayLisa Levin - Aug 4, 2023, 10:32AM
- Twist Bioscience Stock Soars After Q3 Report - Here's WhyVandana Singh - Aug 4, 2023, 10:30AM